Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
Axogen Q1 EPS $(0.190) Misses $(0.150) Estimate, Sales $24.300M Miss $26.190M Estimate
08:19pm, Wednesday, 06'th May 2020Axogen, Inc. Reports First Quarter 2020 Financial Results
08:01pm, Wednesday, 06'th May 2020
ALACHUA, Fla., May 06, 2020 -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today.
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
AxoGen (NASDAQ:AXGN) Upgraded by BidaskClub to Hold
09:38am, Thursday, 30'th Apr 2020
AxoGen (NASDAQ:AXGN) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Thursday, BidAskClub reports. AXGN has been the topic of a number of othe
The VP, Clinical&Translational Sc of AxoGen (AXGN) is Buying Shares
12:04am, Thursday, 30'th Apr 2020
Yesterday, the VP, Clinical&Translational Sc of AxoGen (AXGN), Erick Wayne Devinney, bought shares of AXGN for $683. This recent transaction increases
The VP, Clinical&Translational Sc of AxoGen (NASDAQ: AXGN) is Buying Shares
12:04am, Thursday, 30'th Apr 2020
Yesterday, the VP, Clinical&Translational Sc of AxoGen (
AXGN
–
Research Report
),
Erick Wayne Devinney
, bought shares of AXGN for $683.
This recent transaction increases Erick Wayne Devinney’s h
Earnings Preview: AxoGen (AXGN) Q1 Earnings Expected to Decline
04:34pm, Wednesday, 29'th Apr 2020
AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: AxoGen (AXGN) Q1 Earnings Expected to Decline
04:34pm, Wednesday, 29'th Apr 2020
AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AxoGen (AXGN) Scheduled to Post Earnings on Wednesday
08:36am, Wednesday, 29'th Apr 2020
AxoGen (NASDAQ:AXGN) will issue its quarterly earnings data after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter. AxoGen
AxoGen, Inc (NASDAQ:AXGN) Shares Sold by Nuveen Asset Management LLC
10:52am, Monday, 27'th Apr 2020
Nuveen Asset Management LLC decreased its holdings in shares of AxoGen, Inc (NASDAQ:AXGN) by 3.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commi
Reviewing AxoGen (NASDAQ:AXGN) & InMode (NASDAQ:INMD)
05:36am, Saturday, 25'th Apr 2020
AxoGen (NASDAQ:AXGN) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutiona
